When we hear about the BRCA gene, it’s usually in the context of breast and ovarian cancer. For many, the discovery of a BRCA mutation can feel like a looming shadow, carrying with it a sense of inevitability. But the true story of BRCA is more nuanced—and far more hopeful—than headlines often suggest.

What BRCA Really Does

BRCA1 and BRCA2 are not “cancer genes”. Their normal role is to protect us against cancer. These genes produce proteins that act as part of the cell’s quality-control system. One of their most important jobs is repairing dangerous breaks in DNA, specifically double-strand breaks that can destabilize the genome.

Think of BRCA proteins as skilled editors. Each day, as our cells divide and repair themselves, typos in our DNA code can appear. BRCA steps in, recognizes the error and restores the correct sequence. This process is called homologous recombination repair—a precise method that ensures the genetic “instruction manual” remains accurate.

But BRCA’s protective role doesn’t stop there. Research also shows that BRCA proteins interact with metabolic enzymes, helping regulate whether cells use their energy for repair and maintenance or for uncontrolled growth. In this way, BRCA acts as both a DNA guardian and a metabolic brake.

What Happens When BRCA Mutates

A mutation in BRCA1 or BRCA2 doesn’t cause cancer directly; rather, it weakens the cell’s ability to correct errors. Without this repair system, cells resort to “quick and dirty” fixes that are prone to mistakes. Over time, these mistakes accumulate, some of which may interfere with growth control or apoptosis—the cell’s built-in self-destruct program.

Compounding this problem, the loss of BRCA’s metabolic oversight removes another safeguard. Enzymes like acetyl-CoA carboxylase (ACC), which BRCA normally helps regulate, can become overactive. This fuels fatty acid synthesis, giving cancer cells the raw materials to build new membranes and proliferate rapidly.

In short, BRCA mutations tilt the balance toward instability: weakened DNA repair, disrupted metabolism and impaired cell death signaling. The result is a cellular environment where cancer can take hold more easily.

Why Genes Are Not Destiny

It’s important to remember that carrying a BRCA mutation is not the same as having cancer. Many people with mutations never develop the disease, while others without mutations do. This is because cancer emerges from a web of factors: genetics, environment, inflammation, oxidative stress, mitochondrial health and more.

Studies have shown that certain biochemical markers—like low levels of protective lipids called plasmalogens—can predict breast and ovarian cancer risk with remarkable accuracy, regardless of BRCA status. This highlights the importance of looking beyond single genes to understand the whole biochemical environment.

A Broader Perspective

The story of BRCA is ultimately one of balance and resilience. These genes remind us that our bodies are designed with multiple overlapping layers of protection. When one layer is compromised, others can often step in—through healthy mitochondria, robust antioxidant systems, or lifestyle choices that strengthen cellular repair.

Understanding BRCA not as a sentence, but as one part of a complex network, offers both clarity and hope. It underscores the power of a systems approach to health: one that honors genetics, but also the dynamic interplay of metabolism, environment and lifestyle in shaping our future.

Source: Catie Harris, Ph.D., MBA, CRNP, is the owner of the Philly Wellness Center, which provides both weight and age management along with longevity services, and is located at 834 South St. in Philadelphia. For more information or to make an appointment, call 215-709-9710, email [email protected] or visit www.PhillyWellnessCenter.com.